Physicians Weekly 12 Ways to Optimize CDI Care in Patients With IBD Patients with inflammatory bowel disease (IBD) face a substantially increased risk of Clostridioides difficile (CDI), which can trigger disease flares, increase hospitalization rates, lead to treatment failure, and raise the…
Television health expert Dr Amir Khan has issued important guidance for those taking antibiotics, highlighting crucial dietary steps to safeguard their wellbeing. Each year, millions of antibiotic prescriptions are issued to combat bacterial infections, with roughly one in three people…
AllSci AbbVie (NYSE: ABBV) is tapping up Japan-based Nxera Pharma Co., Ltd. (Tokyo Stock Exchange: 4565) for an exclusive global license to develop and commercialize NXE0033744, a Phase I-stage investigational oral EP4 receptor agonist for inflammatory bowel disease (IBD). Under the deal, Nxera…
Richard H. W. Funk 2 Classical physiological adaptation to heat acclimation 3 HA-induced plasticity of the MPO neural circuit 4 The protective role of HSP70 in heat stress 5 Mechanisms of HA regulation of the gut-microbiota axis 6 Applications and challenges of existing heat acclimation programs for special…
What happens to the bacteria living inside us as societies modernize? A study spanning 12 countries examines how lifestyle, diet, and genetics relate to gut microbial communities and the body's intestinal immune responses. In a recent study published in the journal…
Madrigal Data Presentations at AASLD’s The Liver Meeting 2026 Once patients progress to MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), the risk of adverse liver outcomes increases dramatically: these patients have a 10 to 17 times higher risk…
Presented by The Community Oncology Alliance The 2026 meeting in Denver features more than 265 hours of programming, real-world MASH treatment data, and late-breaking results in rare liver diseases. Hepatology's largest annual gathering heads to the Mile High City this week, as…
GlobeNewswire 04, 2026 (GLOBE NEWSWIRE) -- AltruBio Inc ("AltruBio" or "the Company"), a clinical-stage biotech company developing novel immune modulators to address the unmet need in immunological and inflammatory diseases, today announced that it will host a virtual Research and Development (R&D) Day…
In a small exploratory study, Parkinson's disease patients had smaller deep cervical lymph nodes than healthy controls, and node measurements correlated with clinical severity scores. Subject of Research: Morphology of deep cervical lymph nodes as potential noninvasive markers of Parkinson's…
A phase 1 trial found that a pill of 16 selected beneficial bacteria was safe for stem cell transplant patients and was associated with fewer bloodstream infections.
Gut health, IBD/IBS, reflux, liver disease, and microbiome research.
An article joins this feed when it matches these terms. Each one is also a search of its own.